EDGAR Filing Documents for 0001099910-12-000069

Form 8-K - Current report:

SEC Accession No. 0001099910-12-000069

Filing Date

2012-03-12

Accepted

2012-03-12 11:55:43

Documents

Period of Report

2012-03-09

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	nlnk_8k.htm	8-K	51116
2	POLICY ON STOCKHOLDER RECOMMENDATIONS FOR DIRECTOR NOMINEES.	ex10-1.htm	EX-10.1	5806
3	NEWLINK GENETICS CORPORATION 401(K) PROTOTYPE PLAN AND TRUST, EFFECTIVE AS OF JA	ex10-2.htm	EX-10.2	2278389
4	NEWLINK GENETICS CORPORATION 401(K) ADOPTION AGREEMENT, EFFECTIVE AS OF JANUARY	ex10-3.htm	EX-10.3	1646603
5	MATERIAL MODIFICATION TO THE NEWLINK GENETICS CORPORATION 401(K) ADOPTION AGREEM	ex10-4.htm	EX-10.4	60497
	Complete submission text file	0001099910-12-000069.txt		4043610

Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010

Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555

NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 12682975
SIC: 2834 Pharmaceutical Preparations